FDA sounds alert on anemia drugs
JAMA
.
2007 May 2;297(17):1868-9.
doi: 10.1001/jama.297.17.1868.
Author
Mike Mitka
PMID:
17473287
DOI:
10.1001/jama.297.17.1868
No abstract available
Publication types
News
MeSH terms
Anemia / drug therapy*
Drug Labeling
Erythropoietin / therapeutic use*
Humans
Recombinant Proteins
Risk
United States
United States Food and Drug Administration*
Substances
Recombinant Proteins
Erythropoietin